RecruitingPhase 2NCT04770207

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Intra-tumor Injection of Drug-eluting Microspheres Loading With Chemodrug Plus Checkpoint Inhibitors and/or IL2 for Treatment of Advanced Solid Tumors


Sponsor

Second Affiliated Hospital of Guangzhou Medical University

Enrollment

100 participants

Start Date

Nov 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study tests a technique where small beads loaded with multiple cancer drugs are injected directly into a tumor. Rather than spreading chemotherapy throughout the whole body, this approach delivers drugs right to the cancer site. Researchers want to see how safe and effective this is for people with advanced solid tumors. **You may be eligible if...** - You have an advanced solid (non-fluid) malignant tumor - You are between 18 and 99 years old - Your doctor estimates you have a life expectancy of more than 3 months **You may NOT be eligible if...** - You have a benign (non-cancerous) tumor - Your life expectancy is less than 3 months - You have serious medical conditions that make treatment too risky Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGInjection of drug-eluting microspheres with multiple drugs into solid tumors

Under the guidance of CT, puncture fine needle was used to inject drug-eluting microspheres loading with multiple drugs into the tumor


Locations(1)

The Second Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04770207


Related Trials